CHF174.20
1.16%
SIX Swiss Exchange, Aug 22, 05:30 pm CET
ISIN
CH0012100191
Symbol
TECN

Tecan Group Ltd. Stock price

CHF174.20
+17.70 11.31% 1M
-27.80 13.76% 6M
-28.40 14.02% YTD
-110.20 38.75% 1Y
-185.00 51.50% 3Y
-257.80 59.68% 5Y
+53.60 44.44% 10Y
+134.50 338.79% 20Y
SIX Swiss Exchange, Closing price Fri, Aug 22 2025
+2.00 1.16%

Key metrics

Basic
Market capitalization
CHF2.2b
Enterprise Value
CHF2.1b
Net debt
positive
Cash
CHF397.0m
Shares outstanding
12.7m
Valuation (TTM | estimate)
P/E
35.1 | 25.5
P/S
2.4 | 2.4
EV/Sales
2.4 | 2.3
EV/FCF
15.9
P/B
1.7
Dividends
DPS
CHF3.00
Yield 1Y | 5Y
1.7% | 0.8%
Growth 1Y | 5Y
0.0% | 6.4%
Payout 1Y | 3Y
56.7% | 35.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
CHF906.6m | CHF932.0m
EBITDA
CHF143.0m | CHF168.6m
EBIT
CHF72.7m | CHF97.5m
Net Income
CHF63.1m | CHF86.8m
Free Cash Flow
CHF134.0m
Growth (TTM | estimate)
Revenue
-9.3% | -0.3%
EBITDA
-16.4% | 54.7%
EBIT
-26.4% | 38.7%
Net Income
-37.7% | 28.2%
Free Cash Flow
44.7%
Margin (TTM | estimate)
Gross
35.2%
EBITDA
15.8% | 18.1%
EBIT
8.0%
Net
7.0% | 9.3%
Free Cash Flow
14.8%
Financial Health
Equity Ratio
-
Return on Equity
-
ROCE
5.1%
ROIC
4.6%
Debt/Equity
0.3
More
EPS
CHF5.0
FCF per Share
CHF10.6
Short interest
-
Employees
3k
Rev per Employee
CHF290.0k
Show more

Is Tecan Group Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Tecan Group Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Tecan Group Ltd. forecast:

8x Buy
53%
6x Hold
40%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Tecan Group Ltd. forecast:

Buy
53%
Hold
40%
Sell
7%

Financial data from Tecan Group Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
907 907
9% 9%
100%
- Direct Costs 588 588
10% 10%
65%
319 319
8% 8%
35%
- Selling and Administrative Expenses 182 182
5% 5%
20%
- Research and Development Expense 71 71
11% 11%
8%
143 143
16% 16%
16%
- Depreciation and Amortization 70 70
3% 3%
8%
EBIT (Operating Income) EBIT 73 73
26% 26%
8%
Net Profit 63 63
38% 38%
7%

In millions CHF.

Don't miss a Thing! We will send you all news about Tecan Group Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Tecan Group AG operates as a holding company. The firm engages in the development, production and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. It operates through the following segments: Life Sciences Business and Partnering Business. The Life Sciences Business segment supplies end users with automated workflow solutions, which includes laboratory instruments, software packages, application know-how, services, consumables and spare parts. The Partnering Business segment develops and manufactures original equipment manufacturer instruments and components. The company was founded by Heinz Abplanalp, Heini Maurer, Heini Moeckli and Gallus Blatter on March 18, 1980 and is headquartered in Mannedorf, Switzerland.

Head office Switzerland
CEO Achim Leoprechting
Employees 3,208
Founded 1980
Website www.tecan.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today